Recombinant SARS-CoV-2 Spike antibody (RBD, XBB.1.5 – Omicron)

Catalog No. ABIN7488705

Product Details anti-SARS-CoV-2 Spike Antibody

Target: SARS-CoV-2 Spike

Antibody Type: Recombinant Antibody

Binding Specificity: RBD, XBB.1.5 – Omicron

Reactivity: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Omicron

Host: Mouse

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike antibody is un-conjugated

Application: ELISA

Purpose: Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific) (MALS verified)

Characteristics: Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific) is isolated from a Spike RBD infected Mouse and is recombinantly produced from human 293 cells (HEK293)

Grade: MALS verified

Clone: 9A6A11

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Lyophilized

Storage: -20 °C

Target Details for SARS-CoV-2 Spike

Target: SARS-CoV-2 Spike

Alternative Name: SARS-CoV-2 Spike protein (SARS-CoV-2 Spike Products)

Synonyms: E2 antibody, E2 glycoprotein precursor antibody, Surface Glycoprotein antibody, S antibody

Target Type: Viral Protein

Background: It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.